Acasti Pharma Inc. (17)
Browse by Contract Category
Contracts
-
Form of Grace Therapeutics Inc. First Amendment to the Stockholders Agreement
(Filed With SEC on July 1, 2021)
-
Form of 2017 Amended and Restated Convertible Promissory Note
(Filed With SEC on July 1, 2021)
-
Independent contractor agreement with PFC Business Advisory Services Inc. dated September 14, 2020, and amended March 15, 2021, and June 16, 2021
(Filed With SEC on June 22, 2021)
-
Acasti Pharma Inc., Equity Incentive Plan, as amended August 27, 2020
(Filed With SEC on June 22, 2021)
-
Agreement and Plan of Merger, dated as of May 7, 2021, by and among Acasti, Grace and MergerCo
(Filed With SEC on May 7, 2021)
-
Form of Grace Therapeutics Inc. Stockholders Agreement
(Filed With SEC on July 1, 2021)
-
Form of Second Amendment to 2018 Convertible Note Purchase Agreements and Amendment to Convertible Promissory Notes
(Filed With SEC on July 1, 2021)
-
Form of Amendment to 2018 Convertible Note Purchase Agreements
(Filed With SEC on July 1, 2021)
-
Form of Amendment to 2017 Convertible Note Purchase Agreement and Amended and Restated Convertible Promissory Notes
(Filed With SEC on July 1, 2021)
-
Form of 2017 Convertible Note Purchase Agreement
(Filed With SEC on July 1, 2021)
-
Form of 2018 Convertible Note Purchase Agreement
(Filed With SEC on July 1, 2021)
-
Form of 2017 Convertible Promissory Note
(Filed With SEC on July 1, 2021)
-
Form of 2018 Convertible Promissory Note
(Filed With SEC on July 1, 2021)
-
Acasti Pharma Inc., Stock Option Plan, as amended August 27, 2020
(Filed With SEC on June 22, 2021)
-
Form of Voting Agreement by and between Acasti and each of the Specified Grace Stockholders
(Filed With SEC on May 7, 2021)
-
Retention agreement, dated October 29, 2020 between Acasti Pharma Inc. and Pierre Lemieux
(Filed With SEC on November 16, 2020)
-
Retention agreement, dated October 27, 2020, between Acasti Pharma Inc. and Jan DAlvise
(Filed With SEC on November 16, 2020)